Biohaven Pharmaceutical

+$0.42 (+0.60%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BHVN and other stocks, options, and ETFs commission-free!

About BHVN

Biohaven Pharmaceutical Holding Company Ltd., also called Biohaven Pharmaceutical, is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators.

CEO
Vlad Coric
Employees
825
Headquarters
New Haven, Connecticut
Founded
2013

BHVN Key Statistics

Market Cap
4.84B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
552.80K
High Today
$70.75
Low Today
$68.07
Open Price
$69.46
Volume
263.48K
52 Week High
$100.77
52 Week Low
$43.83

BHVN Earnings

-$2.97
-$1.98
-$0.99
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$2.82 per share
Actual
-$2.97 per share
Replay Earnings Call

You May Also Like

NVEC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure